Clinical use of PET/CT in thyroid cancer diagnosis and management
2006

Clinical Use of PET/CT in Thyroid Cancer Diagnosis and Management

Sample size: 17 publication Evidence: moderate

Author Information

Author(s): Sundram FX

Primary Institution: Subang Jaya Medical Centre, Malaysia

Hypothesis

PET/CT should be a part of routine care in patients with elevated serum thyroglobulin but negative radioiodine whole body scans.

Conclusion

PET/CT is most useful in detecting and managing recurrent papillary thyroid carcinoma in patients with elevated thyroglobulin levels.

Supporting Evidence

  • PET/CT showed lesions consistent with metastases in 15 out of 17 patients.
  • PET/CT sensitivity was reported at 66% for identifying recurrent disease.
  • Diagnostic accuracy for PET/CT was 93% compared to 78% for PET alone.

Takeaway

Doctors can use a special scan called PET/CT to find thyroid cancer that regular tests might miss, especially when blood tests show high cancer markers.

Methodology

The study involved evaluating thyroid cancer patients with elevated thyroglobulin levels and negative I-131 scans using PET/CT imaging.

Limitations

The study may not represent all thyroid cancer patients, as it focused on those with specific conditions.

Participant Demographics

Patients with elevated serum thyroglobulin levels and negative I-131 whole body scans.

Digital Object Identifier (DOI)

10.2349/biij.2.4.e56

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication